Bank of New York Mellon
CKPT

Bank of New York Mellon’s Checkpoint Therapeutics CKPT Stock Holding History

Bank of New York Mellon’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,232
Closed -$44K – 4478
2022
Q3 		$44K Hold
4,232
– – ﹤0.01% 4345
2022
Q2 		$44K Hold
4,232
– – ﹤0.01% 4372
2022
Q1 		$75K Hold
4,232
– – ﹤0.01% 4458
2021
Q4 		$132K Hold
4,232
– – ﹤0.01% 4362
2021
Q3 		$140K Buy
4,232
+2,447
+137% +$72.3K ﹤0.01% 4268
2021
Q2 		$53K Sell
1,785
-10,272
-85% -$285K ﹤0.01% 4321
2021
Q1 		$379K Buy
12,057
+81
+0.7% +$2.71K ﹤0.01% 3828
2020
Q4 		$317K Buy
11,976
+1,182
+11% +$29.9K ﹤0.01% 3802
2020
Q3 		$289K Buy
10,794
+1,721
+19% +$41.3K ﹤0.01% 3733
2020
Q2 		$180K Buy
9,073
+3,527
+64% +$64.3K ﹤0.01% 3817
2020
Q1 		$83K Buy
5,546
+1,064
+24% +$18.8K ﹤0.01% 3887
2019
Q4 		$77K Sell
4,482
-1,927
-30% -$32.3K ﹤0.01% 4055
2019
Q3 		$159K Buy
6,409
+458
+8% +$12.6K ﹤0.01% 3948
2019
Q2 		$181K Buy
5,951
+3,784
+175% +$149K ﹤0.01% 3940
2019
Q1 		$62K Buy
2,167
+167
+8% +$5.33K ﹤0.01% 4072
2018
Q4 		$36K Buy
+2,000
New +$47.6K ﹤0.01% 4096

Other funds holding CKPT

TC
TwinBeech Capital Purchase, New York $965M AUM 0.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon's CKPT Position: Q4 2022 in Review

Bank of New York Mellon sold out of Checkpoint Therapeutics (CKPT) in Q4 2022, closing a stake of 4,232 shares — an estimated $44K sold.

Bank of New York Mellon first reported a position in CKPT in Q4 2018 and held it in 16 quarters. The position peaked at $379K in Q1 2021. 40 funds tracked by Wall St. Rank hold CKPT as of Q4 2022.

  • Bank of New York Mellon reported no remaining Checkpoint Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Bank of New York Mellon sold 4,232 Checkpoint Therapeutics shares in Q4 2022, an estimated $44K.
  • Bank of New York Mellon first reported a position in Checkpoint Therapeutics in Q4 2018 and held it in 16 quarters.
  • Bank of New York Mellon's Checkpoint Therapeutics position peaked at $379K in Q1 2021.
  • 40 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2022.

Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.